GR3003244T3 - Use of oligopeptids for the treatment of cerebral disorders - Google Patents
Use of oligopeptids for the treatment of cerebral disordersInfo
- Publication number
- GR3003244T3 GR3003244T3 GR91401870T GR910401870T GR3003244T3 GR 3003244 T3 GR3003244 T3 GR 3003244T3 GR 91401870 T GR91401870 T GR 91401870T GR 910401870 T GR910401870 T GR 910401870T GR 3003244 T3 GR3003244 T3 GR 3003244T3
- Authority
- GR
- Greece
- Prior art keywords
- treatment
- oligopeptids
- cerebral disorders
- tryptophan
- cerebral
- Prior art date
Links
- 208000018152 Cerebral disease Diseases 0.000 title 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 2
- AJHCSUXXECOXOY-NSHDSACASA-N Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-NSHDSACASA-N 0.000 abstract 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 abstract 1
- 108010038807 Oligopeptides Proteins 0.000 abstract 1
- 102000015636 Oligopeptides Human genes 0.000 abstract 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 108010084389 glycyltryptophan Proteins 0.000 abstract 1
- 206010022437 insomnia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863601398 DE3601398A1 (de) | 1986-01-18 | 1986-01-18 | Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3003244T3 true GR3003244T3 (en) | 1993-02-17 |
Family
ID=6292132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR91401870T GR3003244T3 (en) | 1986-01-18 | 1991-12-02 | Use of oligopeptids for the treatment of cerebral disorders |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4849408A (el) |
| EP (1) | EP0234186B1 (el) |
| JP (1) | JPS62169730A (el) |
| AT (1) | ATE69163T1 (el) |
| DE (2) | DE3601398A1 (el) |
| ES (1) | ES2038603T3 (el) |
| GR (1) | GR3003244T3 (el) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3823464A1 (de) * | 1988-07-11 | 1990-01-18 | Asta Pharma Ag | Neue tryptophandipeptide |
| US5759991A (en) * | 1990-03-29 | 1998-06-02 | Sumitomo Pharmaceutical Company, Limited. | Neurotrophic peptide derivatives |
| US5354738A (en) * | 1992-09-04 | 1994-10-11 | G. D. Searle & Co. | Platelet aggregation inhibitors |
| US5438075A (en) | 1993-03-30 | 1995-08-01 | Skubitz; Keith M. | Oral glutamine to reduce stomatitis |
| EP1206283A2 (en) | 1999-05-17 | 2002-05-22 | Aesgen, Inc. | Improved cellular uptake of bioactive agents |
| WO2004012662A2 (en) * | 2002-08-01 | 2004-02-12 | Aesgen, Inc. | Improved treatment of cancer with glutamine |
| ES2531926T3 (es) * | 2002-12-03 | 2015-03-20 | North Carolina State University | Ligandos de proteínas priones y procedimientos de uso |
| RU2663691C2 (ru) * | 2013-12-13 | 2018-08-08 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" | Фармацевтическая композиция амида n-(6-фенилгексаноил)глицил-l-триптофана с пленочным покрытием и способы ее получения |
| EP3615053A4 (en) * | 2017-04-25 | 2021-07-14 | Temple Otorongo LLC | PHARMACEUTICAL COMPOSITION CONSISTING OF TRYPTOPHAN AND A PHYLLOKININ DERIVATIVE FOR USE IN THE TREATMENT OF PSYCHIATRIC AND PSYCHOLOGICAL DISORDERS |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL175174C (nl) * | 1972-03-31 | 1984-10-01 | Akzo Nv | Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden. |
| JPS51115909A (en) * | 1975-04-01 | 1976-10-13 | Otsuka Pharmaceut Factory Inc | A process for preparing amino acid parenteral injection mixed with a r educing sugar |
| US4110438A (en) * | 1977-03-21 | 1978-08-29 | American Home Products Corporation | Method of treating depression |
| US4405629A (en) * | 1979-05-07 | 1983-09-20 | Massachusetts Institute Of Technology | Process for increasing glycine levels in the brain and spinal cord |
| US4340592A (en) * | 1980-03-14 | 1982-07-20 | Adibi Siamak A | Nutrient compositions and method of administering the same |
| IT1148618B (it) * | 1982-10-11 | 1986-12-03 | Polifarma Spa | Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo |
| GB8319174D0 (en) * | 1983-07-15 | 1983-08-17 | Erba Farmitalia | Biologically active heptapeptides |
| US4687763A (en) * | 1985-02-25 | 1987-08-18 | Massachusetts Institute Of Technology | Composition and method for increasing levels or release of brain serotonin |
| DE3689508T2 (de) * | 1985-10-14 | 1994-05-11 | Nippon Zoki Pharmaceutical Co | Peptide. |
-
1986
- 1986-01-18 DE DE19863601398 patent/DE3601398A1/de not_active Withdrawn
-
1987
- 1987-01-06 DE DE8787100072T patent/DE3774291D1/de not_active Expired - Lifetime
- 1987-01-06 EP EP87100072A patent/EP0234186B1/de not_active Expired - Lifetime
- 1987-01-06 ES ES198787100072T patent/ES2038603T3/es not_active Expired - Lifetime
- 1987-01-06 AT AT87100072T patent/ATE69163T1/de not_active IP Right Cessation
- 1987-01-07 US US07/001,517 patent/US4849408A/en not_active Expired - Fee Related
- 1987-01-13 JP JP62004217A patent/JPS62169730A/ja active Pending
-
1991
- 1991-12-02 GR GR91401870T patent/GR3003244T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3774291D1 (de) | 1991-12-12 |
| DE3601398A1 (de) | 1987-07-23 |
| EP0234186A1 (de) | 1987-09-02 |
| ATE69163T1 (de) | 1991-11-15 |
| EP0234186B1 (de) | 1991-11-06 |
| JPS62169730A (ja) | 1987-07-25 |
| US4849408A (en) | 1989-07-18 |
| ES2038603T3 (es) | 1993-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0441119A3 (en) | The use of l-arginine in the treatment of hypertension and other vascular disorders | |
| CS553490A3 (en) | Transdermal therapeutic system | |
| GB2207055B (en) | Apparatus for use in the treatment of spinal disorders | |
| HU9302384D0 (en) | 2,4-diamino-quinazoline derivatives and medical preparatives containing them | |
| GR3006630T3 (el) | ||
| TW244335B (el) | ||
| EP0326023A3 (en) | Benzamide against cognitive disorders | |
| GR3003244T3 (en) | Use of oligopeptids for the treatment of cerebral disorders | |
| NZ504419A (en) | The use of carvedilol for treating amyloid diseases such as Alzheimer's | |
| EP0275668A3 (en) | Use of ketone derivatives in the treatment of cognitive disorders | |
| AU1029588A (en) | Synergistic combination of azelastine and theophylline or azelastine and beta-mimetics | |
| CA2068630A1 (en) | Use of protein c or activated protein c | |
| TW282455B (el) | ||
| DE3567211D1 (en) | (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use | |
| EP0350738A3 (de) | (S)-Emopamil zur Anwendung bei der Behandlung von Migräne | |
| ZA929390B (en) | The use of D-fenfluramine and fenfluramine compounds in the treatment of hypertension in insulin-resistant subjects. | |
| AU1935988A (en) | Electro-pneumatic device for massages and/or improving the venolymphatic circulation | |
| EP0437026A3 (en) | Use of tandospirone in the treatment of depression | |
| EP0516914A3 (en) | Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation | |
| DE68911509D1 (de) | 26-aminocholesterol und derivate und analoge davon bei der regulierung der cholesterolanhäufung in den körpergefässen. | |
| AU2884489A (en) | Compounds with a psychotropic action, agents containing them, and the use thereof for the treatment and prophylaxis of disorders of the central nervous system | |
| NZ226569A (en) | Process for the two-stage inactivation of viruses using both heat and alkalisation | |
| AU4096789A (en) | The use of lactam derivatives in the treatment of cognitive disorders | |
| AU3406089A (en) | Novel strobilurine derivatives, their preparation and their use | |
| IE900460L (en) | Pharmaceutical composition |